Dr. Norbert W. Bischofberger is an Independent Director at Morphic Holding, Inc. and a President, Chief Executive Officer & Director at Kronos Bio, Inc.
He is on the Board of Directors at Morphic Therapeutic, Inc., Morphic Holding, Inc., Kronos Bio, Inc. and Bayer AG. Dr. Bischofberger was previously employed as a Chief Scientific Officer & Executive VP- Research by Gilead Sciences, Inc. and a Manager-DNA Synthesis Group by Genentech, Inc.
He also served on the board at InCarda Therapeutics, Inc.
He received his undergraduate degree from the University of Innsbruck and a doctorate degree from Swiss Federal Institute of Technology.